Literature DB >> 15258841

[What is needed to develop a headache? Anatomical and pathophysiological implications].

U Reuter1, A May.   

Abstract

The shared anatomical and physiological substrate for headache syndromes is the neural innervation of the cranial circulation. Evidence suggests, that the observed dilatation of vessels in trigeminal pain is not inherent to a specific headache syndrome but rather a feature of the physiology of the trigeminal neural innervation of the cranial circulation. Moreover, the impact of vascular changes for the generation of headaches remains elusive. The trigeminal nerve innervates blood vessels within ipsilateral meninges. Upon activation neuropeptides such as CGRP are released. Blockade of both the trigeminal nerve system and neuropeptides are crucial targets for headache alleviating drugs. While these mechanisms are well known the events within and outside the CNS which initiate headaches are poorly understood. This article will review the anatomy and physiology of the trigeminovascular system which demand renewed consideration of the neural influences in many primary headaches.

Entities:  

Mesh:

Year:  2004        PMID: 15258841     DOI: 10.1007/s00482-004-0350-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  30 in total

1.  Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation.

Authors:  P J Goadsby; L Edvinsson
Journal:  Cephalalgia       Date:  1996-10       Impact factor: 6.292

2.  Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.

Authors:  Hayrunnisa Bolay; Uwe Reuter; Andrew K Dunn; Zhihong Huang; David A Boas; Michael A Moskowitz
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

Review 3.  Sensory nerves in man and their role in primary headaches.

Authors:  L Edvinsson
Journal:  Cephalalgia       Date:  2001-09       Impact factor: 6.292

4.  Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH).

Authors:  C Dahlöf
Journal:  Headache       Date:  1993-04       Impact factor: 5.887

Review 5.  Neurobiology of nitric oxide.

Authors:  H Y Yun; V L Dawson; T M Dawson
Journal:  Crit Rev Neurobiol       Date:  1996

Review 6.  The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.

Authors:  A May; P J Goadsby
Journal:  J Cereb Blood Flow Metab       Date:  1999-02       Impact factor: 6.200

7.  The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea-pigs.

Authors:  D T Beattie; H E Connor
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat.

Authors:  C Tassorelli; S A Joseph
Journal:  Brain Res       Date:  1995-06-05       Impact factor: 3.252

9.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 10.  Current and potential future drug therapies for tension-type headache.

Authors:  Sait Ashina; Messoud Ashina
Journal:  Curr Pain Headache Rep       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.